CFO
Viyash Scientific Limited
Equibles does not estimate personal net worth.
Ramakant is recorded as CFO at Viyash Scientific Limited. Ramakant has spoken on 2 earnings calls across 1 company, most recently for Viyash Scientific Limited on August 12, 2026. Viyash Scientific Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“I am pleased to present the financial performance of We Are Scientific Limited for the first quarter of FI27. We have started FI27 on a strong note with continued momentum in revenue growth. and sustained expansion in margin.”
“I am pleased to present the highlights of our strong financial performance for Q4 and full year Fi26. I begin with the highlights for Q4 Fi26. Total revenues stood at 920 crores, reflecting a year-on-year growth of 19.1%.”
Viyash Scientific Limited
CFO
Transcript header (unverified)
Viyash Scientific Limited
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Earnings Call for the Quarter Ended June 30, 2026
Viyash Scientific Limited
Earnings Call for the Quarter Ended March 31, 2026
Viyash Scientific Limited
